[3] Many peptidomimetics are utilized as FDA-approved drugs, such as Romidepsin (Istodax), Atazanavir (Reyataz), Saquinavir (Invirase), Octreotide (Sandostatin), Lanreotide (Somatuline), Plecanatide (Trulance), Ximelagatran (Exanta), Etelcalcetide (Parsabiv), and Bortezomib (Velcade)
Metabolic Dysfunction as a Driver of Colorectal Cancer Risk Over the past decade, the conceptual framework of colorectal cancer prevention has expanded to include metabolic health as a central determinant of cancer risk
Grab my free recipe pack here
This antioxidant activity is believed to be mediated through the Nrf2 signaling pathway, which enhances the expression of protective proteins such as heme oxygenase-1 (HO-1), glutathione (GSH), and paraoxonase-1 (PON1)